Bo Kreilgård

Title: Bo Kreilgård: Innovator in Therapeutic Formulations

Introduction

Bo Kreilgård is a notable inventor based in Hilleröd, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic formulations. His work focuses on improving the treatment of urinary bladder conditions, showcasing his commitment to enhancing patient care.

Latest Patents

Kreilgård holds a patent for a therapeutic formulation aimed at administering tolterodine with controlled release. This innovative method addresses the treatment of unstable or overactive urinary bladders. The formulation ensures that the active ingredient maintains a substantially constant serum level for at least 24 hours, providing effective and sustained relief for patients.

Career Highlights

Throughout his career, Bo Kreilgård has been associated with Pharmacia Ab, where he has contributed to various research and development projects. His expertise in pharmaceutical formulations has positioned him as a key player in the industry, particularly in the area of controlled release medications.

Collaborations

Kreilgård has worked alongside talented colleagues, including Lene Orup Jacobsen and Ulla Hoeck. Their collaborative efforts have further advanced the research and development of innovative therapeutic solutions.

Conclusion

Bo Kreilgård's contributions to the field of pharmaceuticals, particularly through his patent on tolterodine formulations, highlight his role as an influential inventor. His work continues to impact the treatment of urinary bladder conditions, demonstrating the importance of innovation in healthcare.